Search - tctmd.com

Displaying 101 - 120 of 210

Sort: Relevancy | Date

News Daily News

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

Shelley Wood

July 25, 2022

News Daily News

US Dobutamine Shortage a ‘Huge Problem’—What’s the Solution?

Shelley Wood

July 15, 2022

News Features

A Hole in the Heart for HFpEF? Setbacks, Progress for Interatrial Shunts

Shelley Wood

July 07, 2022

News Daily News

Many Hurdles to Clear Before Cardiac Xenotransplantation Takes Off

Yael L. Maxwell

June 16, 2022

Sweet Spot for Omecamtiv Mecarbil in HFrEF May Lie in Low SBP Patients

Shelley Wood

May 23, 2022

News Daily News

Frailty Does Not Hinder Dapagliflozin’s HFrEF Impact: DAPA-HF Analysis

Caitlin E. Cox

May 03, 2022

News Daily News

CVD Hospitalizations Spiked in Aftermath of 2020 US Election

Michael O'Riordan

April 22, 2022

News Daily News

Infertility in Women Linked to Subsequent Risk of HFpEF

L.A. McKeown

April 19, 2022

News Daily News

Revascularization’s Benefits in HFrEF Linked to Gains in LV Function

Caitlin E. Cox

April 15, 2022

News Daily News

AI-Based Tool IDs Hypertrophic Cardiomyopathy and Cardiac Amyloidosis

Yael L. Maxwell

February 24, 2022

News Conference News THT 2022

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

L.A. McKeown

February 07, 2022

News Conference News THT 2022

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Caitlin E. Cox

February 02, 2022

News Conference News THT 2022

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

Shelley Wood

February 01, 2022

News Daily News

Using Donor Hearts After Circulatory Death Is Feasible for Transplantation

Michael O'Riordan

January 12, 2022

News Opinion CV Team Dispatch

January 2022 News Roundup

L.A. McKeown

January 01, 2022

News Daily News

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Caitlin E. Cox

December 28, 2021

News Daily News

Women Less Likely Than Men to Experience SCD During Sports

Michael O'Riordan

December 21, 2021

News Conference News PCR London Valves 2021

MitraClip Cuts HF Hospitalizations in Real-World Registry: EXPAND

Shelley Wood

November 26, 2021

News Conference News AHA 2021

Risk-Based EHR Alert Doesn’t Improve HF Care or Outcomes: REVEAL-HF

Michael O'Riordan

November 19, 2021

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Shelley Wood

November 08, 2021

Advertisement

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

US Dobutamine Shortage a ‘Huge Problem’—What’s the Solution?

A Hole in the Heart for HFpEF? Setbacks, Progress for Interatrial Shunts

Many Hurdles to Clear Before Cardiac Xenotransplantation Takes Off

Sweet Spot for Omecamtiv Mecarbil in HFrEF May Lie in Low SBP Patients

Frailty Does Not Hinder Dapagliflozin’s HFrEF Impact: DAPA-HF Analysis

CVD Hospitalizations Spiked in Aftermath of 2020 US Election

Infertility in Women Linked to Subsequent Risk of HFpEF

Revascularization’s Benefits in HFrEF Linked to Gains in LV Function

AI-Based Tool IDs Hypertrophic Cardiomyopathy and Cardiac Amyloidosis

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

Using Donor Hearts After Circulatory Death Is Feasible for Transplantation

January 2022 News Roundup

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Women Less Likely Than Men to Experience SCD During Sports

MitraClip Cuts HF Hospitalizations in Real-World Registry: EXPAND

Risk-Based EHR Alert Doesn’t Improve HF Care or Outcomes: REVEAL-HF

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content